Species-specific restriction of complement by HRF20 (CD59) generated by cDNA transfection

Area of Science:

• Immunology
• Molecular Biology
• Cell Biology

Background:

• The 20-kDa homologous restriction factor (HRF20, CD59) is a membrane glycoprotein that prevents complement-mediated cell lysis.
• HRF20 functions by inhibiting the formation of the membrane attack complex (MAC) in the complement system.
• Understanding HRF20's species-specific activity is crucial for its therapeutic applications.

Purpose of the Study:

• To investigate the functional expression and species specificity of human HRF20 in transfected Chinese hamster ovary (CHO) cells.
• To determine if glycosylphosphatidyl inositol (GPI)-anchored HRF20 on CHO cells retains its inhibitory activity against homologous and heterologous complement.

Main Methods:

• Transfection of Chinese hamster ovary (CHO) cells with the cDNA encoding human HRF20.
• Confirmation of cell surface expression of human HRF20 anchored via GPI.
• Assessment of cell resistance to complement-mediated lysis using human, rat, and guinea pig serum.

Main Results:

• Transfected CHO cells successfully expressed human HRF20 on their surface via GPI anchor.
• These cells exhibited resistance to lysis mediated by human complement.
• However, the HRF20-expressing CHO cells remained sensitive to lysis by rat and guinea pig complement.

Conclusions:

• Human HRF20, when expressed on CHO cells, effectively inhibits human complement-mediated cell killing.
• The species specificity of HRF20's inhibitory function is maintained in this heterologous expression system.
• These findings support the role of HRF20 as a key regulator of complement activation with distinct species interactions.